WELL HEALTH TECHS WKN: A2JQV6 ISIN: CA94947L1022 Kürzel: WELL Forum: Aktien Thema: Hauptdiskussion

WELL Health Launches 'WELL AI Decision Support' powered by HEALWELL AI; Empowering Healthcare Providers with Next Generation Decision Support Systems https://www.newswire.ca/news-releases/well-health-launches-well-ai-decision-support-powered-by-healwell-ai-empowering-healthcare-providers-with-next-generation-decision-support-systems-823365904.html

WELL Health Completes Clinic Acquisition and Investment Transactions with HEALWELL AI Inc. (formerly MCI Onehealth), and Forms Strategic Alliance Focused on Developing AI Enabled Disease Detection and Preventative Care Tools for Care Providers https://www.prnewswire.com/news-releases/well-health-completes-clinic-acquisition-and-investment-transactions-with-healwell-ai-inc-formerly-mci-onehealth-and-forms-strategic-alliance-focused-on-developing-ai-enabled-disease-detection-and-preventative-care-tools-for-c-301945558.html

WELL Health Technologies GAAP EPS of C$0.06, revenue of C$170.9M https://seekingalpha.com/news/4001127-well-health-technologies-gaap-eps-of-c006-revenue-of-c1709m • WELL Health Technologies press release (OTC:WHTCF): Q2 GAAP EPS of C$0.06. • Revenue of C$170.9M (+21.8% Y/Y). • WELL Health upgraded guidance, expecting 2023 revenue to be in the upper half of annual guidance of $740M to $760M.  • Annual adjusted EBITDA is expected to increase by more than 10% over 2022 levels.  • WELL also announced that its OceanMD subsidiary signed a multi-year C$38.5M contract. 

WELL Health Reports Record Results for Q2-2023 and Upgrades Guidance for Balance of Year https://www.prnewswire.com/news-releases/well-health-reports-record-results-for-q2-2023-and-upgrades-guidance-for-balance-of-year-301897756.html

https://www.prnewswire.com/news-releases/well-launches-well-health-usa-to-deepen-integration-between-us-lines-of-business-and-facilitate-further-growth-301887112.html

https://www.prnewswire.com/news-releases/well-health-enters-into-automatic-share-purchase-plan-301839548.html

https://ca.sports.yahoo.com/news/stocks-play-well-health-technologies-144400532.html

WELL Health sets quarterly revenue record in 1Q driven by organic growth https://www.proactiveinvestors.com/companies/news/1014887/well-health-sets-quarterly-revenue-record-in-1q-driven-by-organic-growth-1014887.html

https://www.newswire.ca/news-releases/well-health-reports-record-revenue-results-for-q4-and-full-year-2022-and-provides-strong-growth-outlook-for-2023-883762686.html

https://www.baystreet.ca/stocksinplayarticles/38809/WELL-Health-Technologies-Corp38809

https://www.proactiveinvestors.com/companies/news/1005976/well-health-technologies-expected-to-post-4q-earnings-beat-on-track-record-of-outperforming-estimates-analysts-say-1005976.html

...und das Volumen in Toronto ist immerhin gut doppelt so hoch wie sonst üblich.

Schaut ja heute ganz nett aus 🍀

https://www.prnewswire.com/news-releases/well-health-to-participate-at-cibc-western-institutional-conference-301722110.html

WELL Health Technologies Non-GAAP EPS of C$0.07, revenue of C$145.79M https://seekingalpha.com/news/3905691-well-health-technologies-non-gaap-eps-of-c007-revenue-of-c14579m • WELL Health Technologies press release (OTC:WHTCF): Q3 Non-GAAP EPS of C$0.07. • Revenue of C$145.79M (+46.8% Y/Y).

WELL Health Reports Record Revenue and Adjusted EBITDA Results for Q3-2022 and Raises Guidance for Fourth Straight Quarter https://www.well.company/for-investors/news-releases/well-health-reports-record-revenue-and-adjusted-ebitda-results-for-q3-2022-and-raises-guidance-for-fourth-straight-quarter • WELL achieved record quarterly revenues of $145.8 million in Q3-2022 representing a 47% year-over-year (YoY) increase compared to Q3-2021, driven by robust organic growth. • WELL achieved record Adjusted EBITDA(2) of $27.5 million in Q3-2022, an increase of 23% YoY compared to Adjusted EBITDA(2) of $22.3 million for Q3-2021. • WELL’s Virtual Services unit grew by 75% organically YoY and now is the largest of the three main lines of business at 36% of total revenue. • WELL is increasing its guidance for 2022 annual revenue to exceed $565 million from the previous guidance for annual revenue to exceed $550 million.  WELL also expects to generate over $100 million of Adjusted EBITDA(2) in 2022. Furthermore, the Company expects its exit run-rate revenue to approach $700 million by the end of 2023.